Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer

被引:51
|
作者
Yamaguchi, Ken [1 ,2 ]
Abe, Hiroyuki [2 ]
Newstead, Gillian M. [2 ]
Egashira, Ryoko [1 ]
Nakazono, Takahiko [1 ]
Imaizumi, Takeshi [1 ]
Irie, Hiroyuki [1 ]
机构
[1] Saga Univ, Dept Radiol, Fac Med, Saga 8498501, Japan
[2] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA
关键词
Breast; MRI; Molecular subtype; Dynamic contrast-enhanced study; Kinetic pattern; GENE-EXPRESSION PATTERNS; CARCINOMA IN-SITU; DUCTAL CARCINOMA; MUCINOUS CARCINOMA; CLINICOPATHOLOGICAL CHARACTERISTICS; DIAGNOSTIC-ACCURACY; LOBULAR CARCINOMA; FEATURES; PURE; CLASSIFICATION;
D O I
10.1007/s12282-013-0512-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To evaluate the distribution pattern of kinetic parameters in breast cancers with various molecular subtypes. Materials and methods This study was approved by institutional review board and was compliant with HIPAA. We classified 192 invasive breast cancers of 186 patients into four molecular subtypes using hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) results and evaluated the distribution pattern of kinetic parameters (percent volume of kinetic types relative to the tumor volume) in the molecular subtypes. Results In the delayed phase, all three types of kinetic parameter (persistent, plateau, and washout pattern) were observed in each molecular subtype without any dominant type of kinetic parameter. The percentages of washout pattern in the HR? and HER2-type and triple negative (TN) cancers tended to be lower than those in the other molecular subtype cancers. Conclusion Each molecular subtype of invasive breast cancer showed a heterogeneous kinetic pattern in dynamic-contrast magnetic resonance imaging (MRI). The HR+/HER2-cancers and the TN cancers had relatively lower percentages of washout pattern. When a manual assessment of the kinetic parameters is performed, close attention should be paid in order to identify the malignant washout kinetic pattern, particularly in HR+/HER2-cancer and TN cancer.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 50 条
  • [21] Molecular Subtypes of Breast Cancer
    Almarzooq, Raed
    Alrayes, Amal
    Alaradi, Husain
    Abdulla, Hussain
    [J]. BAHRAIN MEDICAL BULLETIN, 2018, 40 (04) : 222 - 225
  • [22] Comparison of the effects of rutaecarpine on molecular subtypes of breast cancer
    Cokluk, Erdem
    Ozman, Zeynep
    Eskiler, Gamze Guney
    Ozkan, Asuman Deveci
    Sekeroglu, Mehmet Ramazan
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (04) : 988 - 993
  • [23] Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
    Warrick, Joshua I.
    Sjodahl, Gottfrid
    Kaag, Matthew
    Raman, Jay D.
    Merrill, Suzanne
    Shuman, Lauren
    Chen, Guoli
    Walter, Vonn
    DeGraff, David J.
    [J]. EUROPEAN UROLOGY, 2019, 75 (01) : 18 - 22
  • [24] Clinical and morphological parameters in breast cancer. Molecular subtypes
    Mathiak, M.
    Warneke, V.
    Schem, C.
    Roecken, C.
    [J]. GYNAKOLOGE, 2013, 46 (06): : 369 - 376
  • [25] Intratumoral heterogeneity and subclonal diversification of early breast cancer
    Yates, Lucy R.
    [J]. BREAST, 2017, 34 : S36 - S42
  • [26] Intratumoral heterogeneity and subclonal diversification of early breast cancer
    Yates, L. R.
    [J]. BREAST, 2017, 32 : S5 - S5
  • [27] Intratumoral heterogeneity contributes to the chemotherapy prognosis of breast cancer
    Li, Yang
    Wang, Maohua
    Yang, Siyuan
    Kuang, Licheng
    Tao, Xinling
    Yang, Jilan
    Zhao, Wentao
    Zhang, Ji
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1268 - +
  • [28] Intratumoral HER2 Heterogeneity in Breast Cancer
    Pegram, Mark
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 535 - 537
  • [29] HIGHLIGHT REPORT: INTRATUMORAL METABOLOMIC HETEROGENEITY OF BREAST CANCER
    Stoeber, Regina
    [J]. EXCLI JOURNAL, 2017, 16 : 1328 - 1329
  • [30] Intratumoral heterogeneity of prognostic multigene signatures for breast cancer
    Hurson, Amber N.
    Hamilton, Alina
    Olsson, Linnea T.
    Kirk, Erin L.
    Calhoun, Benjamin C.
    Geradts, Joseph
    Sherman, Mark E.
    Troester, Melissa A.
    [J]. CANCER RESEARCH, 2020, 80 (21)